Adding Metformin to ADT for Patients with mHSPC: Overall Survival Results from the Multi-Arm, Multi-Stage Randomized Platform Trial STAMPEDE - report from ESMO2024

Professor Silke Gillessen discussing results from STAMPEDE trial assessing the addition of metformin to ADT for patients with mHSPC.

Video: https://medicaldigest.org/scientific-contents/interview:adding-metformin-adt-patients-mhspc-overall-survival-results-multi-arm-multi-stage-randomized-platform-trial-stampede